Burning Rock Biotech Ltd ADR BNR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.82
- Day Range
- $0.79–0.85
- 52-Week Range
- $0.57–3.25
- Bid/Ask
- $0.79 / $0.85
- Market Cap
- $81.32 Mil
- Volume/Avg
- 1,269 / 47,880
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.06
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- —
- Total Number of Employees
- 1,138
- Website
- https://www.brbiotech.com
Valuation
|
Metric
|
BNR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.71 |
Price/Sales | 1.06 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BNR
|
|---|---|
Quick Ratio | 2.83 |
Current Ratio | 3.28 |
Interest Coverage | — |
Quick Ratio
BNR
Profitability
|
Metric
|
BNR
|
|---|---|
Return on Assets (Normalized) | −48.92% |
Return on Equity (Normalized) | −66.35% |
Return on Invested Capital (Normalized) | −65.29% |
Return on Assets
BNR
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Wcnfxkcqx | Xlptm | $209.3 Bil | |
DHR
| Danaher Corp | Czkrxptwn | Ssdcky | $185.5 Bil | |
IQV
| IQVIA Holdings Inc | Ydfjhqyl | Nhwkkyw | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Zztqqftxd | Vdgrjd | $41.0 Bil | |
A
| Agilent Technologies Inc | Qrrghhpgkx | Qymct | $40.3 Bil | |
MTD
| Mettler-Toledo International Inc | Rpmwkvsh | Hyvvxc | $26.4 Bil | |
ICLR
| Icon PLC | Bstkbvzqn | Dkfwgq | $25.2 Bil | |
ILMN
| Illumina Inc | Fwrlvpvp | Kcctfr | $19.6 Bil | |
WAT
| Waters Corp | Yfnyfkxkcw | Ncnxc | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Ymljvvhrc | Whgzw | $17.5 Bil |